Andromeda Surgical

Another major milestone is in the books! In January, Prof. Peter Gilling, MBCHB, MD, FRACS performed his first robotic-assisted holmium laser enucleation of the prostate (HoLEP) procedures at Tauranga Hospital in Tauranga, New Zealand. Prof. Gilling first developed the HoLEP procedure in 1997 and pioneered robotic surgery in New Zealand in 2007. These cases added another historic first to his resume as one of the most accomplished and innovative global urologists. Prof. Gilling is serving as the lead principal investigator of our ongoing ASTRA Study. Dr. Wikus Vermeulen also performed robotic-assisted HoLEP (RoLEP) using Andromeda's platform at Tauranga Hospital as part of the study. We designed our platform with the goal of improving outcomes and reducing the learning curve for endourology procedures. We will be presenting results from the ASTRA Study at various urology conferences this year.

If you’re attending #AUA25, come and see us at the AUA Innovation Nexus on April 25 where we were selected to present

Another #robotic #HoLEP

We're excited to announce our product is live in the clinic and has been used to perform the world's first robotic-assisted prostate enucleation! We'll continue enrolling in the ASTRA study in Chile and New Zealand over the coming months. https://lnkd.in/g_f_qXg9

Great to see so many people interested in Andromeda's story. If you haven't checked out Henry Norton's Surgibots podcast, there's no better place to hear about the latest happenings in surgical robots.

We’re excited to announce we were accepted into FDA’s Safer Technologies Program (STeP)! Andromeda’s mission is to empower every surgeon to deliver optimal results to every patient every time. This is great validation that FDA recognizes our technology’s potential to improve surgical safety. We’re looking forward to collaborating with FDA to bring our product’s benefits to patients and surgeons more efficiently through this program. https://lnkd.in/egRZPAy

In this week’s episode of the DeviceTalks Weekly Podcast, Nick Damiano, co-founder and CEO of Andromeda Surgical, previews his talk at DeviceTalks West by introducing listeners to the potential of #AutonomousSurgery. Still early goings on, but Damiano paints and interesting picture of the future. If you want to see the future register at West.DeviceTalks.com. Speaking of the future, Host Tom Salemi speaks with Brody Galloway, a young MedTech professional who has turned his life’s #healthcare experiences into a love of the industry and a drive to help. And finally, MassDevice Editor Chris Newmarker returns with his Newmarker’s Newsmakers – #SurgicalRobotics, Medtronic, ResMed, Layoffs and, of course, Baxter International Inc. LISTEN HERE: https://lnkd.in/ez99CDcK

30+ Deep Tech startups pitched yesterday at Boost VC Demo Day 🚀 Ones to watch 👀 Acrylic Robotics led by Chloë Ryan Andromeda Surgical led by Nick Damiano Material led by Gabe Elias Natilus led by Aleksey Matyushev Soarce led by Derek Saltzman

Looking forward to sharing the Andromeda Surgical story at DeviceTalks West on October 16th!

We're excited to welcome Michael Nketiah, MBA, RAC to our team as Chief of Regulatory & Quality! Building products that push the boundaries of surgical robotics requires charting new territory with regulatory bodies, and Michael with his creative, first-principles approach is going to be a huge asset to our team. He brings an outstanding 25-year track record as a regulatory & quality leader in the medtech industry. He will lead US and global regulatory matters including strategy, submissions, and interactions with regulatory authorities. Michael previously held leading regulatory & quality roles at Nexalin Technology, InterVenn Bioscience, Tivic Health, Previvo Genetics, and PROCEPT BioRobotics. At PROCEPT he was responsible for obtaining the initial US FDA De Novo Request grant for the Aquablation System and other global market approvals including Australia, Canada, CE Mark, and New Zealand.